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CP-I2, 52f-I is 4-(6,Z-dimethoxyquinozolin-4-yl) piperozine-l-corboxylic ocid isobutyl ester hydrochloride
FICLrfIE 1. Structural formula of cP-12,521-1.
MATEBIAI~ AND METHODS
A wedge spirometer (Meal-Science Electronics, Model 170) was used which generates 1.0 volt/L and 0.1 volt/L/see at the electrical outputs for volume and flow respectively. The output signals were recorded on an xY recorder (~I Model 1100 ~. Variplotter). Volume data were plotted on the x-axis and /tow data on the x-axis of graph paper measuring 11~" by 17", marked at 1/10" intervals. Flow-volume loops are generated in a clockwise direction, the portion below the zero flow line representing inspiration, the upper portion expiration. Twenty subjects from 36 patients with a history of bronchospastic disease were studied. Patients were placed at random into two groups. After one week on placebo, each group received either Tedral or cP-12,521-1 for four weeks, after which they were crossed over 9 Flow-volume loops (rVL) and other pulmonary function data were determined at weekly intervals. 1~
RESULTS AND DISCUSSION
Though many respiratory parameters may be derived from both "conventional" spirometry and flow-volume loops, two that are particularly useful for diagnosis of respiratory ailments can only be derived from the latter. These two are: (1) the "effort dependent" and "mechanical property dependent" portions of the ex- Of the twenty patients studied, three males were excluded because the values for their flow loops placed them in either the normal or the restrictive range. ~ The remaining seventeen patients comprised three males and fourteen females whose average ages were 18 and 35 years, respectively. For the former, an 8-year history of asthma was elicited and the latter a 15-year history. Table I presents the data derived from flow-volume loops of the asthmatics during their treatment periods. The number of patients improved is indicated in Table II , and it can be seen that cP-12, 521-1 and Tedral were equally effective in the management of this group of asthmatic patients. These data on this smaller selected group confirm the findings derived from studies on these patients with the two drugs Tedral and Hoquizil (a metabolite of cP-12,521-1).11 
SUMMARY
A new oral bronchodilator, ca,-12,521-1 was studied in 17 asthmatics. Respiratory flow-volume loops were obtained during an 8-week double-blind randomized crossover study. The usefulness and practicality of this technique in the evaluation of the response of patients to treatment were clearly indicated.
I~SVM~
Un nouveau broncho-dilatateur par voie buceale, le ca,-12,521-1, a 6t6 6tudi6 chez 17 asthmatiques. On a obtenu des courbes de d6bit-volume respiratoire au cours dune 6rude ~t double inconnu d'une duroc de 8 semaines. L'utilit6 et rapplication pratique de cette technique pour 6valuer la r6ponse des malades ce traitement sont rnises en 6vidence.
